SB441, titled the “Junk Lawsuit Prevention Act of 2025,” would amend Arkansas’s existing law regulating discount medical or health-related cards and similar purchasing mechanisms that are not insurance. The bill tightens disclosure requirements for these products by requiring prominent statements that the discounts are not insurance, that consumers have a 30-day cancellation right, and that any discounts must be specifically authorized by separate contracts with listed healthcare providers. It also prohibits misleading, deceptive, or fraudulent marketing and bars the use of insurance-like terms such as “health plan,” “preexisting condition,” or “coverage” in a way that could confuse consumers.
The bill also expands and clarifies enforcement and remedies. It authorizes actions by the Attorney General and injured parties, sets venue options, establishes personal jurisdiction over violators, and provides for injunctive relief, damages, attorney’s fees, costs, and other relief. It increases the statutory recovery to the greater of $100 per card/device or $10,000, allows treble actual damages, and imposes a two-year limitations period with a possible 180-day extension for concealment. It further requires a 30-day pre-suit notice and cure opportunity for consumer actions and makes the remedies cumulative with the Deceptive Trade Practices Act and other penalties. The bill also states that it applies retroactively to alleged violations occurring before its effective date.
The bill’s impact on state law would be to strengthen Arkansas’s regulation of discount health-care access products and related marketing practices, while giving consumers, the Attorney General, and other injured parties broader tools to challenge deceptive sales tactics. It would likely affect businesses that sell medical discount plans, health discount cards, or similar non-insurance products, as well as advertisers and telemarketers promoting those products.
The general sentiment reflected in the voting history appears mixed to negative. The bill passed one third-reading vote 20-11, but later failed on another third-reading vote 28-62, suggesting significant opposition or inability to sustain support. No committee transcript is available, so the record does not show detailed debate, but the vote pattern indicates the measure was controversial.
The main point of contention appears to be the bill’s aggressive enforcement structure and retroactive application. Supporters likely viewed it as consumer protection against deceptive “junk” health discount products, while opponents may have objected to expanded private rights of action, statutory damages, retroactivity, and the possibility of increased litigation exposure for businesses. The 30-day cure process may have been intended to soften that impact, but the overall enforcement scheme still appears to have drawn resistance.
SB441 would amend Arkansas Code Title 4, Chapter 106, Subchapter 2 governing discount cards and similar non-insurance health-related purchasing mechanisms. It would impose stricter disclosure and marketing rules, expand who can sue and where, increase statutory damages and other remedies, and add a notice-and-cure process for consumer lawsuits. The bill would also apply retroactively to alleged past violations, potentially exposing prior conduct to the new enforcement framework.
The voting history suggests the bill had some support but ultimately faced substantial opposition. It cleared one third-reading vote by a narrow margin, then failed a later third-reading vote by a wide margin, indicating that support was not durable and that concerns likely intensified as the bill moved forward. With no committee transcript available, the record shows the outcome more clearly than the debate, but the overall sentiment appears divided and contentious rather than broadly favorable.
The likely points of contention are the bill’s expanded liability and litigation provisions, especially the statutory damages, attorney’s fees, broad venue options, and retroactive application. Businesses selling health discount cards or similar products would likely oppose the measure as overly punitive and litigation-friendly, while consumer advocates and supporters would likely argue that the bill is needed to stop deceptive marketing and protect consumers from products that resemble insurance without being regulated as such. The cure provision may have been a compromise feature, but it does not appear to have resolved the broader dispute.